News

Abbott has secured U.S. Food and Drug Administration (FDA) approval for its CardioMEMS HERO device, a next-generation pulmonary artery (PA) pressure reader for heart failure patients.

The updated reader is 60% smaller and offers built-in WiFi connectivity. It works with an implantable sensor to monitor a patient's PA pressure. 

When patients on GLP-1 therapy also make healthy lifestyle choices—getting enough sleep and exercising, for example—the benefits are significantly greater. 

STS plans on using new research out of Mayo Clinic to help with the development of a surgical risk calculator for adults with this challenging condition.

Image of the A-FLUX Reducer System for chest pain by VahatiCor

The self-expanding, recapturable coronary sinus reducer was associated with a safe implant procedure and "promising" outcomes after six months. Additional research is already underway.

Newer imaging technologies designed to use less radiation have made a considerable impact. In parts of the world where those systems have not yet been implemented, however, radiation dose levels remain quite high. 

artificial intelligence money robot dollar AI

ACR recently voiced its frustrations to Health and Human Services, sharing suggestions for how the agency could spur greater use of this technology. 

money gavel court lawsuit legal judge judgement

Thomas McNalley previously sued Toledo Radiological Associates and Vincent Keiser, MD, alleging the physician failed to diagnose a blood clot in his abdomen. 

DeepHealth, RadNet's technology subsidiary, believes the product can help to address imaging workforce challenges plaguing the EU, similar to the States.

Thumbnail

Identifying patients with alcohol use disorder prior to treatment may help care teams plan ahead and anticipate potential complications.

Radiologists reveal new insight into ancient history

Imaging experts with USC recently shared their observations from the CT imaging of Nes-Hor and Nes-Min—two mummies residing at the California Science Center. 

warning safety alert recall healthcare issue

This represents the latest in a series of safety concerns associated with the Impella platform. The FDA said it is still reviewing the matter and will keep the public informed as new details become available. 

Thumbnail

Cardiovascular disease is already the No. 1 killer among women—and new projections from the American Heart Association suggest things are going to get much worse. There are certain things that clinicians and patients can do, however, to help reverse this trend and save countless lives.

Around the web

The updated reader is 60% smaller and offers built-in WiFi connectivity. It works with an implantable sensor to monitor a patient's PA pressure.